共 120 条
[1]
Castanheira M(2014)Epidemiology and carbapenem resistance mechanisms of carbapenem-non-susceptible J Antimicrob Chemother 69 1804-14
[2]
Deshpande LM(1990) collected during 2009–11 in 14 European and Mediterranean countries Antimicrob Agents Chemother 34 52-7
[3]
Costello A(2013)Outer membrane protein D2 catalyzes facilitated diffusion of carbapenems and penems through the outer membrane of J Antimicrob Chemother 68 1772-80
[4]
Davies TA(2009)Complexity of resistance mechanisms to imipenem in intensive care unit strains of Clin Microbiol Rev 22 582-610
[5]
Jones RN(2014)Antibacterial-resistant Antimicrob Agents Chemother 58 2740-6
[6]
Trias J(2014): clinical impact and complex regulation of chromosomally encoded resistance mechanisms Int J Antimicrob Agents 43 349-52
[7]
Nikaido H(2011)In vitro assessment and multicenter cohort study of comparative nephrotoxicity rates associated with colistimethate versus polymyxin B therapy Clin Infect Dis 53 879-84
[8]
Fournier D(2012)Risk factors for acute kidney injury in patients treated with polymyxin B or colistin methanesulfonate sodium J Infect 65 80-7
[9]
Richardot C(1987)Incidence of and risk factors for colistin-associated nephrotoxicity in a large academic health system Chemotherapy 33 183-8
[10]
Muller E(2012)Incidence and predictors of acute kidney injury associated with intravenous polymyxin B therapy Clin Microbiol Rev 25 450-70